Skip to main content

Valrubicin Side Effects

Medically reviewed by Drugs.com. Last updated on Feb 21, 2024.

Applies to valrubicin: intravesical solution.

Serious side effects of Valrubicin

Along with its needed effects, valrubicin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Other side effects of Valrubicin

Some side effects of valrubicin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Rare

For Healthcare Professionals

Applies to valrubicin: intravesical solution.

Local

Local adverse reactions associated with valrubicin usually occurred during or shortly after instillate and resolve within one to seven days after the instillation is removed from the bladder.[Ref]

Very common (10% or more): Any local bladder symptom (88%)

Common (1% to 10%): Procedure related local burning symptoms[Ref]

Genitourinary

Very common (10% or more): Urinary frequency (61%), urinary urgency (57%), dysuria (56%), bladder spasm (31%), hematuria (29%), bladder pain (28%), urinary incontinence (22%), urinary tract infection (15%), cystitis (15%)

Common (1% to 10%): Nocturia, urinary retention, microscopic hematuria, urethral pain, pelvic pain, gross hematuria

Frequency not reported: Poor urine flow, urethritis[Ref]

General

The most common side effects were local bladder symptoms, including urinary frequency, urinary urgency, and dysuria.[Ref]

Gastrointestinal

Common (1% to 10%): Abdominal pain, nausea, diarrhea, vomiting, flatulence

Frequency not reported: Tenesmus[Ref]

Nervous system

Common (1% to 10%): Headache, dizziness

Frequency not reported: Taste loss[Ref]

Dermatologic

Common (1% to 10%): Rash

Frequency not reported: Pruritus, local skin irritation[Ref]

Cardiovascular

Common (1% to 10%): Vasodilation[Ref]

Hematologic

Common (1% to 10%): Anemia[Ref]

Metabolic

Common (1% to 10%): Hyperglycemia, peripheral edema

Frequency not reported: Nonprotein nitrogen increased[Ref]

Musculoskeletal

Common (1% to 10%): Back pain, myalgia[Ref]

Respiratory

Common (1% to 10%): Pneumonia[Ref]

Other

Common (1% to 10%): Asthenia, malaise, chest pain, fever

References

1. Product Information. Valstar (valrubicin). Medeva Pharmaceuticals. 2001;PROD.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.